Bernd Brust

CEO, Maravai Lifesciences

Bernd Brust brings more than 30 years of global leadership experience in life sciences and scientific instrumentation, with a focus on commercial operations, strategic growth, and innovation. Mr. Brust was appointed CEO and a Board Member of Maravai LifeSciences in June 2025.

Bernd brings more than 30 years of leadership experience in the life sciences industry. Previously, Bernd served as Executive Chairman and CEO of Antylia Scientific, a global provider of tools and solutions for diagnostic testing, sample preparation, biological monitoring, and environmental analysis. The company was a portfolio investment of private equity firm GTCR, which acquired Antylia in 2019 and sold it to Brookfield Asset Management for approximately $1.3 billion in 2025.

Before that, he was President and CEO of Qualicaps, a global provider of capsule manufacturing and processing equipment for the pharmaceutical industry, which was acquired by Mitsubishi Chemical Holdings in 2013.

Earlier in his career, Mr. Brust was Chief Commercial Operations Officer at Life Technologies Corporation, responsible for a $3.5 billion global business. He also held senior leadership positions at Invitrogen Corporation (a predecessor of Life Technologies) and GE Medical Systems, where he gained broad experience across operational, sales, and business development functions.